Orphan Therapeutics Accelerator Announces Foundational Partnerships
Founding Members Chiesi, BIAL Lead Initial Funding;
Landmark Bio, Uncommon Cures Join Clinical Development Network;
DVLP Medicines, Vibe Bio to Provide Integrated AI-based Solutions
AI for biopharma business development: finding the right assets faster
By combining human expertise with AI-powered analysis, we’re helping biopharma companies make faster, more informed business development decisions.
3 key ways AI-powered analysis supports drug development
Artificial intelligence-powered pipeline analysis is emerging as a tool that can help teams make better, faster drug development decisions.
What causes AI hallucinations & how Vibe Bio delivers results you can trust
Artificial Intelligence (AI) is a broad umbrella of technologies, covering a huge swathe of algorithmic applications.
The Impact Review – Founding Vibe Bio
The Impact Review article explores Alok Tayi’s personal experience with rare disease drove him towards a mission – to fund cures for rare diseases.
STAT – Upending drug industry financing
This article looks at how Vibe Bio CEO, Alok Tayi, is seeking to upend drug industry financing.
Forbes – Alok Tayi’s new start-up is putting drug development into patients’ hands
This article examines how Vibe Bio’s Founder and CEO is putting drug development into patients’ hands.
